5-[4-(3,6,9,12-tetraoxapentadec-14-ynyl)piperazin-1-yl]-5-(4-phenoxyphenyl)pyrimidine-2,4,6-trione | 1233816-90-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 5-[4-(3,6,9,12-tetraoxapentadec-14-ynyl)piperazin-1-yl]-5-(4-phenoxyphenyl)pyrimidine-2,4,6-trione
• CAS: 1233816-90-4
• 化学式: C₃₁H₃₈N₄O₈
• 分子量: 594.665
• InChiKey: IIKTVHBUKCYKNH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.36
• 重原子数：
  43.0
• 可旋转键数：
  17.0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  127.9
• 氢给体数：
  2.0
• 氢受体数：
  10.0

反应信息

• 作为反应物：
  描述：

  5-[4-(3,6,9,12-tetraoxapentadec-14-ynyl)piperazin-1-yl]-5-(4-phenoxyphenyl)pyrimidine-2,4,6-trione 、 3-(2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)ethoxy)-2-fluoropyridine 在 copper(ll) sulfate pentahydrate 、 sodium ascorbate 作用下， 以 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 2.5h， 以62%的产率得到5-[4-(2-{2-[2-(2-{1-[2-(2-{2-[2-(2-fluoropyridin-3-yloxy)ethoxy]ethoxy}ethoxy)ethyl]-1H-1,2,3-triazol-4-yl-methoxy}ethoxy)ethoxy]ethoxy}ethyl)piperazin-1-yl]-5-(4-phenoxyphenyl)pyrimidine-2,4,6-trione
  参考文献：
  名称：

  A New Generation of Radiofluorinated Pyrimidine-2,4,6-triones as MMP-Targeted Radiotracers for Positron Emission Tomography

  摘要：

  Radiolabeled C-5-disubstituted pyrimidine-2,4,6-triones have recently been suggested by our group as a class of potent matrix metalloproteinase (MMP) targeted radiotracers that can noninvasively visualize activated MMPs by means of positron emission tomography (PET). MMPs belong to the zinc- and calcium-dependent endopeptidases which are involved in the proteolytic degradation of components of the extracellular matrix (ECM) but also are capable of processing and releasing bioactive molecules such as growth factors, proteinase inhibitors, and cytokines. Locally increased levels of activated MMPs modulate and contribute to the progression of various diseases, such as cancer, atherosclerosis, stroke, arthritis, and others. Therefore, activated MMPs are suitable biological targets for the specific and noninvasive visualization of aforementioned pathologies in vivo. On the basis of our recent results, we here describe a series of new fluorinated pyrimidine-2,4,6-triones of the second generation with maintained MAP inhibition potencies (IC50 = 4-605 nM), which are fine-tuned toward more hydrophilic versions, and show the improved biodistribution behavior of one selected radiofluorinated pyrimidine-2,4,6-trione by means of small-animal PET.

  DOI：

  10.1021/jm201142w
• 作为产物：
  描述：

  5-(4-phenoxyphenyl)pyrimidine-2,4,6-trione 在 N-溴代丁二酰亚胺(NBS) 、 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 0.33h， 生成 5-[4-(3,6,9,12-tetraoxapentadec-14-ynyl)piperazin-1-yl]-5-(4-phenoxyphenyl)pyrimidine-2,4,6-trione
  参考文献：
  名称：

  A New Generation of Radiofluorinated Pyrimidine-2,4,6-triones as MMP-Targeted Radiotracers for Positron Emission Tomography

  摘要：

  Radiolabeled C-5-disubstituted pyrimidine-2,4,6-triones have recently been suggested by our group as a class of potent matrix metalloproteinase (MMP) targeted radiotracers that can noninvasively visualize activated MMPs by means of positron emission tomography (PET). MMPs belong to the zinc- and calcium-dependent endopeptidases which are involved in the proteolytic degradation of components of the extracellular matrix (ECM) but also are capable of processing and releasing bioactive molecules such as growth factors, proteinase inhibitors, and cytokines. Locally increased levels of activated MMPs modulate and contribute to the progression of various diseases, such as cancer, atherosclerosis, stroke, arthritis, and others. Therefore, activated MMPs are suitable biological targets for the specific and noninvasive visualization of aforementioned pathologies in vivo. On the basis of our recent results, we here describe a series of new fluorinated pyrimidine-2,4,6-triones of the second generation with maintained MAP inhibition potencies (IC50 = 4-605 nM), which are fine-tuned toward more hydrophilic versions, and show the improved biodistribution behavior of one selected radiofluorinated pyrimidine-2,4,6-trione by means of small-animal PET.

  DOI：

  10.1021/jm201142w

文献信息

• Radiofluorinated Pyrimidine-2,4,6-triones as Molecular Probes for Noninvasive MMP-Targeted Imaging
  作者：Hans-Jörg Breyholz、Stefan Wagner、Andreas Faust、Burkhard Riemann、Carsten Höltke、Sven Hermann、Otmar Schober、Michael Schäfers、Klaus Kopka

  DOI：10.1002/cmdc.201000013

  日期：2010.5.3

  biological targets for the specific visualization of such pathologies, in particular by using radiolabeled MMP inhibitors (MMPIs). The aim of this work was to develop a radiofluorinated molecular probe for noninvasive in vivo imaging for the detection of up‐regulated levels of activated MMPs in the living organism. Fluorinated MMPIs (26, 31 and 38) based on the pyrimidine‐2,4,6‐trione lead structure

  基质金属蛋白酶（MMP）是依赖锌和钙的内肽酶。代表甲氧西林超家族的一个亚家族，MMP参与细胞外基质成分的蛋白水解降解。MMP表达失调，MMP失调和MMP活性局部升高是各种疾病（例如癌症，动脉粥样硬化，中风，关节炎等）的共同特征。因此，活化的MMP是用于这种病理学的具体可视化的合适的生物学靶标，特别是通过使用放射性标记的MMP抑制剂（MMPI）。这项工作的目的是开发一种用于非侵入性体内成像的放射性氟化分子探针，用于检测活生物体中活化的MMP的上调水平。氟化的MMPi（26，31和38）基于嘧啶-2,4,6-三酮铅结构合成了RO 28-2653（1），并在体外评估了其对MMP的抑制力。实现了第一个18 F标记的原型MMP靶向示踪剂[ 18 F] 26的放射性合成和体内生物分布，该原型适合通过正电子发射断层扫描（PET）进行分子成像。